bg
A

Allakos (ALLK)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allakos (ALLK)

Allakos Inc. is a clinical stage biopharmaceutical company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory and proliferative disea... Read more

  • USD0.69
  • USD0.69
  • USD0.64
  • USD3.41
  • 10.40%
  • --
  • 717.35k
  • 330.12k
  • 61M
  • 0.54
  • -71.20%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.